• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for rheal towner

rheal towner

Beating The Odds

Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

June 15, 2017

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

Filed Under: News, Technology Ventures News Tagged With: agreement, cancer, cells, chemo, denis corin, develop, drug, license, liver cancer, medical, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, otcqb, q biomed, qbio, rajiv gandhi centre for biotechnology, research, rgcb, Rheal, rheal towner, rights, scientist-news, therapy, Towner, uttrocide b

Love and other drugs

February 9, 2016

Brain scans of people who are in love look similar to scans of drug addicts.

Filed Under: News Tagged With: addiction, brain, brain scan, cocaine, drug, drugs, elicit, functional mri, heart, love, MRI, newsok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, Rheal, rheal towner, romance, scientist-news, stanford, stephen prescott, Towner, valentine, Valentine's Day

Research brings new view of difficult urinary disorder

November 30, 2015

Contrast MRI may lead to better diagnosis for bladder pain syndrome

Filed Under: News Tagged With: bladder, bladder pain syndrome, contrast-enhanced MRI, interstitial cystitis, leaky bladder, MRI, OUHSC, Rheal, rheal towner, robert hurst, scientist-news, Towner, urinary disorder

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace